Johnson and Johnson 2010 Annual Report Download - page 24

JOHNSON & JOHNSON 2010 ANNUAL REPORT22
Having heard Joseph Lister speak in 1876, Robert Wood Johnson
was inspired to start a company to manufacture the first
mass-produced sterile surgical dressings and sutures according
to Lister’s methods, helping to make surgery safer and save lives.
With his brothers, James Wood Johnson and Edward Mead Johnson, he founded
Johnson & Johnson, a company that has come to be known for its caring.
Caring inspires the people of
Johnson & Johnson to advance health
and well-being. Just as the Johnson
brothers did, we embrace research and
science, bring forward innovative ideas,
products and services, and work with
partners in health care to touch lives
throughout the world.
“Meeting unmet needs in health care,
one of our most important mandates, is
to foster innovation both internally and
through external collaborations,” says
Garry Neil, M.D., Corporate Vice
President, Corporate Office of Science &
Technology. “Throughout our business
segments, we have talented and driven
scientists whose work is at the heart of
product innovations we continue to bring
forward, just as we’ve done for 125 years.”
Dr. Frederick Barnett Kilmer was the
Company’s first scientific director and
chief publicity officer, from 1889–1934.
Dr. Kilmer spread knowledge of antiseptic
methods for treating wounds, furthered
the scientific direction of the Company,
and helped earn trust for its expanding
product lines among physicians and
patients. His tenure saw many pioneering
firsts, including steam sterilization
techniques, first aid kits, JOHNSON’S®
Baby Powder and BAND-AID® Brand
Adhesive Bandages—invented by
employee Earle Dickson.
As Johnson & Johnson grew, new
companies were added. With new
companies came great scientists.
Dr. Philip Levine studied human blood
and discovered many of the subgroups in
blood typing. His work led to the
development of RhoGAM®, the first
Rho (D) immunoglobulin product to treat
hemolytic disease of the newborn and a
product that has helped save the lives of
countless babies. Dr. Paul Janssen,
a Belgian scientist and one of the 20th
century’s most innovative and inspiring
pharmaceutical researchers, discovered
haloperidol and led teams credited with
discovering 80 medicines.
The promise of new innovations inspires
Johnson & Johnson scientists today.
Miri Seiberg, Shawn Stad and Marie-Pierre
de Béthune are among the select scientists
who share the distinction of having received
the Johnson Medal for Research and
Development for outstanding science and
technology relating to contributions to a
specific product or process. Named after
the late General Robert Wood Johnson,
who authored Our Credo in 1943, it is the
most prestigious award for research and
development in the corporation. Each of
the honoree’s experiences demonstrates
that caring for others combined with
innovative research and science makes
all the difference.
“Johnson & Johnson enables us to be
at the cutting edge of technology,” says
Miri Seiberg, Ph.D., Distinguished
Research Fellow at the Skin Biology
group, Johnson & Johnson Consumer
Companies, Inc. “We can combine
knowledge and technology with
innovative ideas to create better products
and better serve our customers.”
Seiberg is a 2003 recipient for the
discovery and development of the
“Total-Soy” skin care platform
technology.
“As scientists make new discoveries
and gain a deeper understanding of the
human body, more doors open to
develop new products,” says Shawn Stad,
Staff Engineer at DePuy, Inc., a 2010
recipient for his role in developing the
VIPER®2 Minimally Invasive Spine
System. “There will always be a need for
medical intervention, and there will
always be value in doing it better.”
For Marie-Pierre de Béthune, Ph.D.,
Vice President, External Innovation at
Tibotec, BVBA, receiving the medal shows
that ultimately the work makes a
difference for patients. “The highest
recognition I can get is when patients
thank us for the drugs,” says de Béthune
who was awarded the recognition in 2009
for the discovery and development of
PREZISTA™ (darunavir), for the treatment
of HIV-1 infection. “Each patient who says
thank you is as breathtaking as the next.
You don’t get used to it.”
A PORTRAIT OF INNOVATION Since 1886, generations of Johnson & Johnson employees have brought forth transformative
ideas and products. Every invention, every product, every breakthrough has been and will be powered by people and inspired by
their caring. These are just some of our landmark inventions and products. A guide to the photo is on the inside back cover.
Learn more at www.jnj.com/ourhistory.
125 Years of Caring
JOHNSON & JOHNSON